ResearcherYale Cancer CenterNo recent work listed
Lingeng Lu
Matched on ORCID iD 0000-0001-9871-0809; OpenAlex author ID A5101569049. Sources: OpenAlex.
Their work
- Papers
- 15 (first author 4, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 26
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 5 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper
Papers 15
- A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. Last author DOI 10.3390/cancers13112565↗
- Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001654↗
- Current Approaches to Pancreatic Cancer Screening. First author DOI 10.1016/j.ajpath.2018.09.013↗
- Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
- Aspirin Use and Reduced Risk of Pancreatic Cancer. First author DOI 10.1158/1055-9965.epi-16-0508↗
- Exosomes: potential for early detection in pancreatic cancer. Co-author DOI 10.2217/fon-2015-0005↗
- Plasma metabolite biomarkers for the detection of pancreatic cancer. First author DOI 10.1021/pr501135f↗
- Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
- Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". Co-author DOI 10.1093/aje/kwv025↗
- Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. Co-author DOI 10.1093/aje/kwv026↗
- Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdv236↗
- Case-control study of aspirin use and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-13-1284↗
- ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. First author DOI 10.1093/aje/kws458↗
- Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821268d1↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Harvey A. Risch · 10 shared papers, 2011–2019 · strength 0.67
- Paper Exosomes: potential for early detection in pancreatic cancer. DOI 10.2217/fon-2015-0005↗
- Paper Current Approaches to Pancreatic Cancer Screening. DOI 10.1016/j.ajpath.2018.09.013↗
- Paper Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". DOI 10.1093/aje/kwv025↗
- Herbert Yu · 8 shared papers, 2011–2017 · strength 0.42
- Paper Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". DOI 10.1093/aje/kwv025↗
- Paper Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. DOI 10.1093/aje/kwv026↗
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Béatrice Fervers · 2 shared papers, 2020–2021 · strength 0.31
- Yixing Wu · 2 shared papers, 2020–2021 · strength 0.31
- Mark S. Kidd · 5 shared papers, 2011–2017 · strength 0.30
- Paper Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". DOI 10.1093/aje/kwv025↗
- Paper Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. DOI 10.1093/aje/kwv026↗
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Hongmei Zeng · 2 shared papers, 2011–2021 · strength 0.17
- Yu-Tang Gao · 3 shared papers, 2013–2017 · strength 0.16
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Paper Plasma metabolite biomarkers for the detection of pancreatic cancer. DOI 10.1021/pr501135f↗
- Paper ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. DOI 10.1093/aje/kws458↗
- Quanxing Ni · 3 shared papers, 2013–2017 · strength 0.16
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Paper Plasma metabolite biomarkers for the detection of pancreatic cancer. DOI 10.1021/pr501135f↗
- Paper ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. DOI 10.1093/aje/kws458↗
- Samantha A. Streicher · 2 shared papers, 2014–2017 · strength 0.12
- Ankit Chhoda · 1 shared paper, 2019 · strength 0.12
- James J. Farrell · 1 shared paper, 2019 · strength 0.12
- Guoxiang Xie · 1 shared paper, 2015 · strength 0.05
- Wei Ping Jia · 1 shared paper, 2015 · strength 0.05
- H. Bas Bueno-de-Mesquita · 1 shared paper, 2015 · strength 0.04
- Rachel Ε. Neale · 1 shared paper, 2015 · strength 0.04
- Halcyon G. Skinner · 1 shared paper, 2015 · strength 0.04
- Kristin E. Anderson · 1 shared paper, 2015 · strength 0.04
- Sean Patrick Cleary · 1 shared paper, 2015 · strength 0.04
- Patrick Maisonneuve · 1 shared paper, 2015 · strength 0.04
- Cristina Bosetti · 1 shared paper, 2015 · strength 0.04
- Michelle Cotterchio · 1 shared paper, 2015 · strength 0.04
- Mary A. Waterhouse · 1 shared paper, 2015 · strength 0.04
- Paige M. Bracci · 1 shared paper, 2015 · strength 0.04
- Gloria M. Petersen · 1 shared paper, 2015 · strength 0.04
- Carlo La Vecchia · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.